Ciclesonide 80 μG or 320 μG once daily achieves lung function improvement comparable with budesonide 200 μG twice daily in patients with persistent asthma

被引：0

作者：

Hansel, T ^{[1
]}

Biberger, C ^{[1
]}

Engelstätter, R ^{[1
]}

机构：

[1] Royal Brompton Hosp, London, England

来源：

THORAX | 2004年 / 59卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：71 / 71

页数：1

共 50 条

[31] Budesonide 200 μ g and 400 μ g once daily via Turbuhaler® dry powder inhaler significantly improves asthma-specific quality of life (QOL) in adult patients with stable asthma.
Dukes, E
Kemp, J
Raymundo, A
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S69 - S69
[32] An 12-week, Randomised, Parallel-group, Phase III Study comparing the Efficacy of Once-daily Formoterol/Budesonide Turbuhaler 4.5/160 μg and Twice-daily Budesonide Swinghaler 200 μg During Step-down in Well Controlled Asthma
Nakwan, Narongwit
Perkleang, Thitima
Tamsawai, Thanida
Taptawee, Pattarawadee
EUROPEAN RESPIRATORY JOURNAL, 2017, 50
[33] A Post-Hoc Analysis Of Asthma Control And Lung Function Following Treatment With Ciclesonide 80 μg HFA-MDI Twice Daily In Subjects With Mild-to-Moderate Persistent Asthma Previously Receiving Low Dose Fluticasone Propionate/Salmeterol
Prenner, B.
Meltzer, E. O.
Desai, S. Y.
Karafilidis, J.
Walsh, J.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB85 - AB85
[34] Efficacy of once- and twice-daily administration of budesonide via Turbuhaler® as initial therapy in patients with mild persistent asthma
Herjavecz, I
Blomqvist, P
Serrano, A
RESPIRATORY MEDICINE, 1999, 93 (04) : 230 - 235
[35] Adverse effects of inhaled budesonide (800 μg) on growth and collagen turnover in children with asthma:: A double-blind comparison of once-daily versus twice-daily administration
Heuck, C
Wolthers, OD
Kollerup, G
Hansen, M
Teisner, B
JOURNAL OF PEDIATRICS, 1998, 133 (05): : 608 - 612
[36] DOUBLE-BLIND COMPARISON OF INTRANASAL FLUTICASONE PROPIONATE, 200 MU-G, ONCE-DAILY WITH 200 MU-G TWICE-DAILY IN THE TREATMENT OF PATIENTS WITH SEVERE SEASONAL ALLERGIC RHINITIS TO RAGWEED
DOLOVICH, J
OCONNOR, M
STEPNER, N
SMITH, A
SHARMA, RK
ANNALS OF ALLERGY, 1994, 72 (05): : 435 - 440
[37] Evaluation of the efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol, 80 or 160 μg once daily, for the treatment of seasonal allergic rhinitis
Ratner, Paul
Jacobs, Robert
Mohar, Dale
Huang, Holly
Desai, Shailesh Y.
Hinkle, Joseph
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2010, 105 (06) : 471 - 479
[38] Comparative effects of low dose single inhaler Budesonide/Formoterol given once versus twice daily in patients with mild persistent asthma
Filipovic, M.
ALLERGY, 2008, 63 : 608 - 608
[39] Efficacy of beclomethasone dipropionate HFA 200 μg once daily in chronic obstructive pulmonary disease and bronchial asthma
Tatsis, G.
Kotsifas, K.
Filaditaki, V.
Makrantoni, G.
Boulia, S.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2007, 35 (03) : 361 - 373
[40] Efficacy and safety of fluticasone propionate 250 μg administered once daily in patients with persistent asthma treated with or without inhaled corticosteroids
Berger, WE
Ford, LB
Mahr, T
Nathan, RA
Crim, C
Edward, L
Wightman, DS
Lincourt, WR
Rickard, K
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2002, 89 (04) : 393 - 399

← 1 2 3 4 5 →